Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GNR
|
|||
| Former ID |
DIB003546
|
|||
| Drug Name |
Vivaglobin
|
|||
| Synonyms |
16% subcutaneous immunoglobulin therapy (primary immunodeficienies/ITP), CSL Behring
Click to Show/Hide
|
|||
| Indication | Nervous system disease [ICD-11: 8A00-8E7Z; ICD-10: G64, G90.0] | Approved | [1], [2] | |
| Company |
CSL Behring
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00520494) Efficacy and Safety of Vivaglobin in Previously Untreated Patients With Primary Immunodeficiency. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.